OAS1 and pancreatic neoplasm: Our results demonstrated that in both Bxpc-3 (siRNC: 402 ± 3.05, siRNA3: 145± 11.67) and Panc-1 (siRNC: 450 ± 6.51, siRNA3: 140± 1.00) cell lines, the invasion ability of pancreatic cancer cells was significantly reduced after OAS1 knockdown (Figure 4C, Figure S2B).